首页> 外国专利> genetically engineered plasmid vector, genetically engineered bacterial cell, genetically engineered e.coli, fusion polypeptide, homodimer molecule and pharmaceutical composition.

genetically engineered plasmid vector, genetically engineered bacterial cell, genetically engineered e.coli, fusion polypeptide, homodimer molecule and pharmaceutical composition.

机译:基因工程质粒载体,基因工程细菌细胞,基因工程大肠杆菌,融合多肽,同源二聚体分子和药物组合物。

摘要

Novel cell surface molecules recognized by monoclonal antibodies against a cell surface molecule of lymphocytic cells that play an important role in autoimmune diseases and allergic diseases have been isolated, identified, and analyzed for their functions. The cell surface molecules are expressed specifically in thymocytes, lymphocytes activated by ConA-stimulation, and peripheral blood lymphocytes, and induce cell adhesion. Antibodies against the cell surface molecules significantly ameliorate pathological conditions of autoimmune diseases and allergic diseases.
机译:已分离,鉴定和分析了针对淋巴细胞的细胞表面分子的单克隆抗体识别的新型细胞表面分子,所述淋巴细胞表面分子在自身免疫性疾病和变应性疾病中起重要作用。细胞表面分子在胸腺细胞,通过ConA刺激激活的淋巴细胞和外周血淋巴细胞中特异性表达,并诱导细胞粘附。针对细胞表面分子的抗体可显着改善自身免疫性疾病和过敏性疾病的病理状况。

著录项

  • 公开/公告号BR9807788B1

    专利类型

  • 公开/公告日2010-11-16

    原文格式PDF

  • 申请/专利权人

    申请/专利号BR19989807788

  • 发明设计人 TAKUYA TAMATANI;KATSUNARI TEZUKA;

    申请日1998-02-27

  • 分类号A01K67/027;C07K14/705;A61K38;A61K38/17;A61K39/395;A61P29;A61P37;A61P37/02;C07K9;C07K14/47;C07K16/18;C07K16/28;C07K19;C12N1/21;C12N5;C12N5/10;C12N15/02;C12N15/09;C12N15/12;C12P21/02;C12P21/08;C12R1/19;C12R1/91;

  • 国家 BR

  • 入库时间 2022-08-21 18:07:22

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号